Cytosorbents Co. (NASDAQ:CTSO – Get Free Report) was the recipient of a large decrease in short interest in the month of May. As of May 15th, there was short interest totalling 1,460,000 shares, a decrease of 5.8% from the April 30th total of 1,550,000 shares. Based on an average trading volume of 102,400 shares, the […]
StockNews.com began coverage on shares of Cytosorbents (NASDAQ:CTSO – Free Report) in a research note issued to investors on Sunday. The firm issued a hold rating on the medical research company’s stock. Several other equities analysts have also issued reports on CTSO. B. Riley reissued a buy rating and set a $3.00 target price on […]
EverSource Wealth Advisors LLC increased its stake in shares of Barrick Gold Corp (NYSE:GOLD – Free Report) (TSE:ABX) by 175.6% during the 4th quarter, according to its most recent filing with the SEC. The institutional investor owned 1,794 shares of the gold and copper producer’s stock after acquiring an additional 1,143 shares during the period. […]
Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN – Get Free Report) was the target of a significant growth in short interest in May. As of May 15th, there was short interest totalling 191,500 shares, a growth of 441.0% from the April 30th total of 35,400 shares. Based on an average daily trading volume, of 185,700 shares, the days-to-cover […]
HC Wainwright reissued their buy rating on shares of Coherus BioSciences (NASDAQ:CHRS – Free Report) in a research report sent to investors on Friday, Benzinga reports. The brokerage currently has a $12.00 price target on the biotechnology company’s stock. Separately, Truist Financial cut their price target on shares of Coherus BioSciences from $8.00 to $7.00 […]